T Cell Defects in Atopic Dermatitis: Therapeutic Consequences

  • R. Jarisch
Conference paper


Immunologie studies relating to atopic dermatitis (AD) reveal, besides a variety of different pathologic findings, two characteristic alterations of humoral and cellular immunity: raised IgE levels and evidence of dysfunction in cell-mediated immunity (reviewed by [7, 15].


Atopic Dermatitis Specific Immunotherapy Primary Immunodeficiency Disease Levamisole Therapy Eczematous Skin Lesion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Alfonso A (1976) Transfer factor in atopic dermatitis. Lancet 1:1352CrossRefGoogle Scholar
  2. 2.
    Alomar A, Giméez-Camarasa J, Moragas J de (1978) The use of Levamisole in atopic dermatitis. ArchDermatol 114:1316–1319Google Scholar
  3. 3.
    Barnetson R, White G (1979) Cell-mediated immune responses to staphylococcus aureus in atopic eczema. J Clin Lab Immunol 2:205–209Google Scholar
  4. 4.
    Burgio GR, Nespoli L, Ugazio AG (1978) Atopy as a minimal immunodeficiency? Eur J Pediatr 129:221–229PubMedCrossRefGoogle Scholar
  5. 5.
    Frick OL, Mills J (1980) Sendai virus-induced IgE antibody production in the mouse (Abstract). J Allergy Clin Immunol 65:166Google Scholar
  6. 6.
    Frick OL, German DF, Mills J (1979) Development of allergy in children: I. Association with virus infections. J Allergy Clin Immunol 63:228–241PubMedCrossRefGoogle Scholar
  7. 7.
    Hanifin JM, Lobitz WC (1977) Newer concepts of atopic dermatitis. Arch Dermatol 113:663–670PubMedCrossRefGoogle Scholar
  8. 8.
    Hovmark A, Ekre HPT (1978) Failure of transfer factor therapy in atopic dermatitis. Acta Derm Venereol (Stockh) 58:497–500Google Scholar
  9. 9.
    Hsieh KH (1980) Effects of Cyclophosphamide, Levamisole and Concanavalin A on the in vitro IgE biosynthesis. Ann Allergy 44:91–94PubMedGoogle Scholar
  10. 10.
    Ida S, Hooks JJ, Siraganian RP, Notkins AL (1977) Enhancement of IgE-mediated histamine release from human basophils by viruses: role of interferon. J Exp Med 145:892PubMedCrossRefGoogle Scholar
  11. 11.
    Jarisch R (1979) Die atopische Dermatitis. In: Ekzeme in der Praxis. Hygiene-Verlag, Vienna, pp 19–24Google Scholar
  12. 12.
    Jarisch R, Sandor I, Stingl G, Pehamberger H, Pichler W (1978) Levamisole therapy in atopic dermatitis (double blind study). Arch Dermatol Res 261:96–97Google Scholar
  13. 13.
    Jarisch R, Eibl M, Sandor I, Boltz A (1981) Influence of dialysable transfer factor on IgE concentrations in patients with atopic dermatitis. Allergy 36:99–105PubMedCrossRefGoogle Scholar
  14. 14.
    Katz DH (1978) Control of IgE antibody production by suppressor substances. J Allergy Clin Immunol 1:44–55CrossRefGoogle Scholar
  15. 15.
    Katz ST, Wuepper K, Gigli I, Hanifin JM, Provost TT, Sams WM, Soter NA, Storrs FJ (1979) II. Eczematous and immunologie diseases. J Invest Dermatol 73:414–433CrossRefGoogle Scholar
  16. 16.
    Knapp W, Posch B (1980) Concanavalin A-induced suppressor cell activity: opposing effects of hydrocortisone. J Immunol: 124:168–172PubMedGoogle Scholar
  17. 17.
    Ogden BE, Krueger GG, Hill HR (1979) Lymphocyte suppressor activity in atopic eczema. Clin exp Immunol 35:269–275PubMedGoogle Scholar
  18. 18.
    Fuenmayor MC di Prisco de, Champion RH (1979) Specific hyposensitization in atopic dermatitis. Br J Dermatol 101:697–700CrossRefGoogle Scholar
  19. 19.
    Schuster DL, Bongiovanni BA, Pierson DL, Barbara JF, Wong DTO, Levinson AI (1980) Selective deficiency of a T cell subpopulation in active atopic dermatitis. J Immunol 124:1662–1667PubMedGoogle Scholar
  20. 20.
    Schut BT, Dooren LJ, Uittenbogaart CH, Schellekens PTA, Eijsvoogel VP (1979) Cellular immunity in patients with the Wiskott-Aldrich syndrome before and after administration of transfer factor: a follow up study. Immunology 36:1–12PubMedGoogle Scholar
  21. 21.
    Spitler LE, Levin AS, Stites DP, Fudenberg HH, Pirofsky B, August CS, Stiehm ER, Hitzig WH, Gatti RA (1972) The Wiskott-Aldrich syndrome, results of transfer factor therapy. J Clin Invest 51:3216–3224PubMedCrossRefGoogle Scholar
  22. 22.
    Stingl G, Gazze LA, Czarnecki N, Wolff K (1980) Suppressor Defekt bei Neurodermitis constitutionalis (Abstract). Arch Dermatol Res 267:199Google Scholar
  23. 23.
    Strannegärd IL, Hanson LA, Lindholm L, Mobacken H, Strannegärd Ö (1975) Transfer factor in severe atopic disease. Lancet 2:702PubMedCrossRefGoogle Scholar
  24. 24.
    Symoens J, Rosenthal M, Brabander M de, Goldstein G (1979) Immunoregulation with Levamisole. Semin Immunopathol 2:49–68Google Scholar
  25. 25.
    Tada T(1975) Regulation of reaginic antibody formation in animals. Prog Allergy 19:122–183PubMedGoogle Scholar
  26. 26.
    Thulin H, Ellegaard J, Thestrup-Pedersen K, Zachariae H (1977) Long-term transfer factor treatment in severe atopic dermatitis. Acta Allergol (Copenh) 32:236–247Google Scholar
  27. 27.
    Thurman GB, Marshall GD, Goldstein AL (1980) In vivo generation of suppressor T cells in athymic mice by thymosin (Abstract 3.3.29) 4th International Congress of Immunology, ParisGoogle Scholar
  28. 28.
    Wara DW, Amman AJ (1978) Thymosin in treatment of children with primary immunodeficiency disease. Transplant Proc 10:203–209PubMedGoogle Scholar
  29. 29.
    White CE, Hanifin JM (1978) Levamisole therapy in atopic dermatitis. Arch Dermatol 114:1314–1315PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1981

Authors and Affiliations

  • R. Jarisch
    • 1
  1. 1.I. Universitäts-HautklinikWienGermany

Personalised recommendations